Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Medalist Diversified REIT | MDRR | Oct 11, 2024 | 12.24 | -0.81 |
Medalist Diversified REIT A Pref | MDRRP | Oct 11, 2024 | 24.72 | +0.24 |
Medallion Bank F Pref | MBNKP | Oct 11, 2024 | 25.10 | -0.32 |
Medallion Financial | MFIN | Oct 11, 2024 | 8.29 | +1.10 |
MediaAlpha | MAX | Oct 11, 2024 | 18.83 | +3.12 |
Mediaco A | MDIA | Oct 11, 2024 | 1.16 | +4.50 |
Medical Properties Trust | MPW | Oct 11, 2024 | 4.75 | -4.04 |
MediciNova | MNOV | Oct 11, 2024 | 1.78 | -9.62 |
Medifast | MED | Oct 11, 2024 | 18.02 | +0.11 |
MEDIROM Healthcare Technologies ADR | MRM | Oct 11, 2024 | 2.72 | +1.91 |
MediWound | MDWD | Oct 11, 2024 | 16.81 | +0.36 |
Mednax | MD | Oct 11, 2024 | 12.11 | +0.92 |
Medpace | MEDP | Oct 11, 2024 | 347.91 | +0.93 |
Medtronic | MDT | Oct 11, 2024 | 89.36 | +0.57 |
Mega Matrix | MPU | Oct 11, 2024 | 1.38 | -0.72 |
Megacap 300 Growth Index ETF Vanguard | MGK | Oct 11, 2024 | 325.04 | +0.07 |
Megacap 300 Index ETF Vanguard | MGC | Oct 11, 2024 | 208.68 | +0.51 |
Megacap 300 Value Index ETF Vanguard | MGV | Oct 11, 2024 | 129.89 | +1.07 |
MEI Pharma | MEIP | Oct 11, 2024 | 2.70 | 0.00 |
Meihua International Medical Technologies | MHUA | Oct 11, 2024 | 0.74 | -1.21 |
MeiraGTx Holdings | MGTX | Oct 11, 2024 | 4.25 | +5.46 |
Meiwu Technology | WNW | Oct 11, 2024 | 0.79 | -3.13 |
Melar Acquisition I | MACI | Oct 11, 2024 | 9.95 | 0.00 |
Melar Acquisition I | MACIU | Oct 11, 2024 | 10.13 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Oct 11, 2024 | 7.89 | +0.51 |
MercadoLibre | MELI | Oct 11, 2024 | 2 091.16 | +2.48 |
Mercantile Bank | MBWM | Oct 11, 2024 | 43.91 | +5.33 |
Mercer International | MERC | Oct 11, 2024 | 7.38 | +4.38 |
Merchants Bancorp | MBIN | Oct 11, 2024 | 44.87 | +0.31 |
Merchants Bancorp B | MBINO | Oct 11, 2024 | 25.18 | +0.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.